www.thinktwice.com    About Us    Vaccine Books      


Cancer

      Numerous studies have confirmed a link between vaccinations and higher rates of cancer. Children who contract childhood ailments such as measles, mumps and chickenpox are significantly protected against various cancers later in life. Children who are vaccinated against childhood diseases are prevented from developing this anti-cancer protection. They are trading a reduced risk of infections for an increased risk of developing cancer later in childhood or as an adult.

      The studies on this webpage provide strong evidence that infections protect against cancer while vaccines -- which are designed to prevent infections -- increase cancer rates. (For a more extensive collection of peer-reviewed studies on vaccines, cancer, and natural infections, read Miller's Review of Critical Vaccine Studies.)


400 Critical Vaccine Studies

    Studies on Vaccines, Cancer and Natural Infections:

  • A mumps infection -- but not mumps vaccination -- protects women against ovarian cancer.
    [Abstract]

  • Women with prior infections of mumps, measles, rubella or chickenpox were significantly less likely to develop ovarian cancer.
    [Abstract]

  • Adults with previous infections of influenza, measles, mumps or chickenpox are less likely to develop malignant melanoma.
    [Abstract]

  • A history of chickenpox is significantly protective against the risk of developing a brain tumor.
    [Abstract]

  • Childhood diseases experienced early in life protect against many different types of cancer later in life.
    [Abstract]

  • Measles and other childhood infections protect against cancer of the lymph system.
    [Abstract]

  • Early exposure to infectious disease significantly reduces the risk of childhood leukemia.
    [Abstract]

  • MMR vaccination increases the risk of childhood leukemia.
    [Abstract]



    Miller's Review

    Miller's Review of Critical Vaccine Studies
    400 Important Scientific Papers
    Summarized for Parents and Researchers

    by Neil Z. Miller

    Foreword by Gary Goldman, PhD

    Copyright © 2016.
    (In stock. Now available!)



    Many people sincerely believe that all vaccines are safe, adverse reactions are rare, and no peer-reviewed scientific studies exist showing that vaccines can cause harm. This book -- Miller's Review of Critical Vaccine Studies -- provides the other side of the story that is not commonly told. It contains summaries of 400 important scientific papers to help parents and researchers enhance their understanding of vaccinations.

    "This book should be required reading for every doctor, medical student and parent. Reading this book will allow you to make better choices when considering vaccination."
    --David Brownstein, MD

    "Neil Miller's book is a tour de force and a clarion voice championing the cautionary principle: 'When in doubt, minimize risk.' Let's talk science. Read this book. The truth will keep you and your children protected." --Bradford S. Weeks, MD

    "This is a well-researched work that raises a number of important considerations about our current vaccination practices. Through studies with commentaries, the reader is led on a journey that bypasses the typical myopic view our society has toward vaccines." --Brandon Horn, PhD, JD, LAc, Chief Academic Officer, American University of Complementary Medicine

    336 Pages / Copyright © 2016
    Code: MRO $21.95



Additional Studies Linking Vaccines and Cancer

      The studies below provide additional evidence of scientific links between vaccines and cancer, including leukemia, lymphomas, and chromosome changes leading to mutations. Studies also document links between the polio vaccine, a monkey virus (SV-40), mesotheliomas, brain tumors, bone cancers, and more.

Vaccines, Leukemia and Lymphomas:

  • Bichel J. Post-vaccinial lymphadenitis developing into Hodgkin's disease. Acta Med Scand, 1976, 199: 523-525.

  • Stewart AM, et al. Aetiology of childhood leukaemia. Lancet, 1965, Oct 16, 2: 789-790.

  • Glathe H, et al. Evidence of tumorigenic activity of candidate cell substrate in vaccine production by the use of anti-lymphocyte serum. Development Biol Std, 1977, 34: 145-148.

  • Bolognesi, DP, "Potential Leukemia Virus Subunit Vaccines: Discussion", Can Research, Feb 1976, 36(2 pt 2):655-656.

  • Colon, VF, et al. Vaccinia Necrosum as a Clue to Lymphatic Lymphoma, Geriatrics, Dec 1968, 23:81-82.

  • Park-Dincsoy, H et al. Lymphoid Depletion in a case of Vaccinia Gangrenosa", Laval Med, Jan 1968, 39:24-26.

  • Hugoson, G et al. The Occurrence of Bovine Leukosis Following the Introduction of Babesiosis Vaccination Bibl Haemat, 1968, 30:157-161.

  • Hartstock. Post-vaccinial Lymphadenitis: Hyperplasia of Lymphoid Tissue That Simulates Malignant Lymphomas, Apr 1968, Cancer, 21(4):632-649.

  • Allerberger, F. An Outbreak of Suppurative Lymphadenitis Connected with BCG Vaccination in Austria-1990/1991, Am Rev Respir Disorder, Aug 1991, 144(2) 469.

  • Omokoku B, Castells S. Post-DPT inoculation cervical lymphadenitis in children. NY State J Med 1981 Oct;81(11):1667-1668.

Vaccines and Chromosome Changes Leading to Mutations:

  • Knuutila, S et al. An Increased Frequency of Chromosomal Changes and SCEs in Cultured Lymphocytes of 12 Subjects Vaccinated Against Smallpox. Hum Genet, 1978 Feb 23; 41(1):89-96.

  • Cherkeziia, SE, et al. Disorders in the Murine Chromosome Apparatus Induced By Immunization with a Complex of Anti-viral Vaccines. Vopr Virusol, 1979 Sept Oct, (5):547-550. [SCE means sister chromatid exchange and is an indication that genetic mutations are occurring, which could possibly lead to cancer-causing mutations.]

The Polio Vaccine Has Been Linked to Cancer:

  • Shah, K and Nathanson, N. "Human exposure to SV40." American Journal of Epidemiology, 1976; 103: 1-12.
  • Innis, M.D. "Oncogenesis and poliomyelitis vaccine." Nature, 1968; 219:972-73.
  • Soriano, F., et al. "Simian virus 40 in a human cancer." Nature, 1974; 249:421-24.
  • Weiss, A.F., et a;. "Simian virus 40-related antigens in three human meningiomas with defined chromosome loss." Proceedings of the National Academy of Science 1975; 72(2):609-13.
  • Scherneck, S., et al. "Isolation of a SV-40-like papovavirus from a human glioblastoma." International Journal of Cancer 1979; 24:523-31.
  • Stoian, M., et al. "Possible relation between viruses and oromaxillofacial tumors. II. Research on the presence of SV40 antigen and specific antibodies in patients with oromaxillofacial tumors." Virologie, 1987; 38:35-40.
  • Stoian, M., et al. "Possible relation between viruses and oromaxillofacial tumors. II. Detection of SV40 antigen and of anti-SV40 antibodies in patients with parotid gland tumors." Virologie, 1987; 38:41-46.
  • Bravo, M.P., et al. "Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers." Neoplasma, 1988; 35:285-88.
  • O'Connell, K., et al. "Endothelial cells transformed by SV40 T-antigen cause Kaposi's sarcoma-like tumors in nude mice." American Journal of Pathology, 1991; 139(4):743-49.
  • Weiner, L.P., et al. "Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy." New England Journal of Medicine, 1972; 286:385-90.
  • Tabuchi, K. "Screening of human brain tumors for SV-40-related T-antigen." International Journal of Cancer 1978; 21:12-17.
  • Meinke, W., et al. "Simian virus 40-related DNA sequences in a human brain tumor." Neurology 1979; 29:1590-94.
  • Krieg, P., et al. "Episomal simian virus 40 genomes in human brain tumors." Proceedings of the National Academy of Science 1981; 78:6446-50.
  • Krieg, P., et al. "Episomal Simian Virus 40 Genomes in Human Brain Tumors." Proceedings of the National Academy of Sciences of the USA, 1981, 78(10):6446-6450.
  • Krieg, P., et al. "Cloning of SV40 genomes from human brain tumors." Virology 1984; 138:336-40.
  • Geissler, E. "SV40 in human intracranial tumors: passenger virus or oncogenic 'hit-and-run' agent?" Z Klin Med, 1986; 41:493-95.
  • Geissler, E. "SV40 and Human Brain Tumors." Progress in Medical Virology, 1990; 37:211-222.
  • Bergsagel, D.J., et al. "DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood." New England Journal of Medicine, 1992; 326:988-93.
  • Martini, M., et al. "Human Brain Tumors and Simian Virus 40." Journal of the National Cancer Institute, 1995, 87(17):1331.
  • Lednicky, JA., et al. "Natural Simian Virus 40 Strains are Present in Human Choroid Plexus and Ependymoma Tumors." Virology, 1995, 212(2):710-17.
  • Tognon, M., et al. "Large T Antigen Coding Sequence of Two DNA Tumor Viruses, BK and SV-40, and Nonrandom Chromosome Changes in Two Gioblastoma Cell Lines." Cancer Genetics and Cytogenics, 1996, 90(1): 17-23.
  • Carbone, M., et al. "SV-40 Like Sequences in Human Bone Tumors." Oncogene, 1996, 13(3):527-35.
  • Pass, HI, Carbone, M., et al. "Evidence For and Implications of SV-40 Like Sequences in Human Mesotheliomas." Important Advances in Oncology, 1996, pp. 89-108.
  • Rock, Andrea. "The Lethal Dangers of the Billion Dollar Vaccine Business," Money, (December 1996), p. 161. [Article]
  • Carlsen, William. "Rogue virus in the vaccine: Early polio vaccine harbored virus now feared to cause cancer in humans." San Francisco Chronicle (July 15, 2001), p. 7. [Article: Research by Susan Fisher, epidemiologist, Loyola University Medical Center.]
  • Bookchin, D. and Schumacher J. "Tainted polio vaccine still carries its threat 40 years later." The Boston Globe (January 26, 1997). [Article]
  • Rosa, FW., et al. "Absence of antibody response to simian virus 40 after inoculation with killed-poliovirus vaccine of mothers offspring with neurological tumors." New England Journal of Medicine, 1988; 318:1469.
  • Rosa, FW., et al. Response to: "Neurological tumors in offspring after inoculation of mothers with killed poliovirus vaccine." New England Journal of Medicine, 1988, 319:1226.
  • Martini, F., et al. "SV-40 Early Region and Large T Antigen in Human Brain Tumors, Peripheral Blood Cells, and Sperm Fluids from Healthy Individuals." Cancer Research, 1996, 56(20):4820-4825.

Please read our DISCLAIMER. Copyright © 1996-2017. All Rights Reserved.